Drug Information Association Logo

FDA Deputy Commissioner to Deliver Keynote Address at DIA 23rd Annual EDM Conference

Horsham, PA, USA — Jan 08, 2010

The Drug Information Association (DIA) will host its 23rd Annual Electronic Document Management (EDM) Conference: Global Content Management in an Electronic World from February 16-19 in National Harbor, MD.
 
The DIA EDM Conference is the oldest and most respected event of its kind. This year’s conference will feature three parallel tracks focusing on core document management practices, including aspects of the changing evolution of eStandards, regulations, technology, and the growing volume of information generated along the drug development continuum. The four-day conference will:

  • Feature a keynote address from Dr. Joshua M. Sharfstein, Principal Deputy Commissioner, Food and Drugs, FDA
  • Discuss strategies for optimizing the management and repurposing of information across the enterprise for submissions to worldwide regulatory authorities,
  • Explore how far our industry has progressed toward realizing the shared regulatory and industry goal of an e Only environment,
  • Examine the shift from traditional paper records management toward a fully electronic document management system including eSignatures
  • Discuss emerging standards and technologies via the EDM Reference Model

Regulatory Authority Day on February 18 will feature key FDA and EMEA officials who will provide insight into the future direction of CBER and CDER, International regulations, electronic clinical submissions, FDA regulatory operations. The day will conclude with an interactive FDA town hall session. 

More than 40 companies will be on hand to showcase their product and services in the interactive exhibit hall. 

Register for the 23rd Annual EDM Conference.

 

 

 

 

###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.